2026 Lisa H. Butterfield: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	72	2191	2012	1062	963	283	22364

Overview

Lisa H. Butterfield is affiliated with the University of California, San Francisco in the United States. Their research primarily focuses on immunotherapy, cancer immunology, and molecular biology, with significant contributions to oncology and microbiology.

The scientist has published extensively in the fields of medicine and immunology and microbiology, with particular attention to cancer research. Their subfields of study include:

Oncology
Immunology
Molecular Biology
Genetics
Cancer Research

The main topics of their work cover a range of areas in cancer immunotherapy and immune responses, specifically:

Immunotherapy and Immune Responses
Cancer Immunotherapy and Biomarkers
CAR-T cell therapy research
Glioma Diagnosis and Treatment
Cutaneous Melanoma Detection and Management
Immune cells in cancer
Pancreatic and Hepatic Oncology Research

Butterfield's frequent co-authors include:

John M. Kirkwood
Juraj Adamik
Samantha Bucktrout
Paul V. Munson
Walter J. Storkus

Their work has been published in a variety of scientific venues, with recurring publications in the following journals and conference proceedings:

Journal for ImmunoTherapy of Cancer
Regular and Young Investigator Award Abstracts
Journal of Translational Medicine
Nature Medicine
Cancer Immunology Research

Notable recent papers include:

"Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial," 2022, Nature Medicine
"Immunotherapy combination approaches: mechanisms, biomarkers and clinical observations," 2023, Nature Reviews Immunology
"Hallmarks of Resistance to Immune-Checkpoint Inhibitors," 2022, Cancer Immunology Research
"Mass cytometry detects H3.3K27M-specific vaccine responses in diffuse midline glioma," 2020, Journal of Clinical Investigation
"Distinct metabolic states guide maturation of inflammatory and tolerogenic dendritic cells," 2022, Nature Communications

Best Publications

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink;Sangeetha M. Reddy;Jianjun Gao;Shaojun Zhang

2486
Citations
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.

Hideho Okada;Pawel Kalinski;Ryo Ueda;Aki Hoji

773
Citations
Immunotherapy of Cancer in 2012

John M. Kirkwood;Lisa H. Butterfield;Ahmad A. Tarhini;Hassane Zarour

590
Citations
A Phase I/II Trial Testing Immunization of Hepatocellular Carcinoma Patients with Dendritic Cells Pulsed with Four α-Fetoprotein Peptides

Lisa H. Butterfield;Antoni Ribas;Vivian B. Dissette;Yohan Lee

483
Citations
Current Developments in Cancer Vaccines and Cellular Immunotherapy

Antoni Ribas;Lisa H. Butterfield;John A. Glaspy;James S. Economou

429
Citations
A comparison of gene transfer methods in human dendritic cells

J F Arthur;L H Butterfield;M D Roth;L A Bui

418
Citations
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial.

F. Stephen Hodi;Sandra Lee;David F. McDermott;David F. McDermott;Uma N. Rao

411
Citations
Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab

Ahmad A. Tarhini;Howard D Edington;Lisa H. Butterfield;Yan Lin

396
Citations
Determinant Spreading Associated with Clinical Response in Dendritic Cell-based Immunotherapy for Malignant Melanoma

Lisa H. Butterfield;Antoni Ribas;Vivian B. Dissette;Saral N. Amarnani

394
Citations
T-cell responses to HLA-A*0201 immunodominant peptides derived from α-fetoprotein in patients with hepatocellular cancer

Lisa H. Butterfield;Antoni Ribas;Wilson S. Meng;Vivian B. Dissette

391
Citations
Dendritic Cell-Based Cancer Vaccines.

Patricia M. Santos;Lisa H. Butterfield

390
Citations
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma

Ahmad A. Tarhini;Haris Zahoor;Yan Lin;Usha Malhotra

373
Citations
Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade.

Jun Zhou;Kathleen M. Mahoney;Kathleen M. Mahoney;Anita Giobbie-Hurder;Fengmin Zhao

357
Citations
Next Generation of Immunotherapy for Melanoma

John M. Kirkwood;Ahmad A. Tarhini;Monica C. Panelli;Stergios J. Moschos

282
Citations
State of the Art Review: Cancer vaccines

Lisa H Butterfield

282
Citations
Novel technologies and emerging biomarkers for personalized cancer immunotherapy.

Jianda Yuan;Priti S. Hegde;Raphael Clynes;Periklis G. Foukas;Periklis G. Foukas

258
Citations
Generation of Human T-cell Responses to an HLA-A2.1-restricted Peptide Epitope Derived from α-Fetoprotein

Lisa H. Butterfield;Andrew Koh;Wilson Meng;Charles M. Vollmer

256
Citations
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.

Sacha Gnjatic;Vincenzo Bronte;Laura Rosa Brunet;Marcus O. Butler

249
Citations
Antigen-Specific Immune Responses and Clinical Outcome After Vaccination With Glioma-Associated Antigen Peptides and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Children With Newly Diagnosed Malignant Brainstem and Nonbrainstem Gliomas

Ian F. Pollack;Regina I. Jakacki;Lisa H. Butterfield;Ronald L. Hamilton

243
Citations
Genetic Immunization for the Melanoma Antigen MART-1/Melan-A Using Recombinant Adenovirus-transduced Murine Dendritic Cells

Antoni Ribas;Lisa H. Butterfield;William H. McBride;Syed M. Jilani

241
Citations
α-Fetoprotein-specific Genetic Immunotherapy for Hepatocellular Carcinoma

Charles M. Vollmer;Fritz C. Eilber;Lisa H. Butterfield;Antoni Ribas

236
Citations

Frequent Co-Authors

James S. Economou University of California, Los Angeles

John M. Kirkwood University of Pittsburgh

Antoni Ribas University of California, Los Angeles

Hideho Okada University of California, San Francisco

William H. McBride University of California, Los Angeles

John A. Glaspy University of California, Los Angeles

Ahmad A. Tarhini Cleveland Clinic

Theresa L. Whiteside University of Pittsburgh

Francesco M. Marincola National Institutes of Health

Pawel Kalinski Roswell Park Comprehensive Cancer Center

External Links

Personal website of Lisa H. Butterfield

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can open diverse career pathways. Nursing, especially psychiatric nursing, offers varied roles supporting patient care and research.

Starting with foundational programs, students may find it easier to enter the field through the best easiest lpn programs to get into. Licensed Practical Nurse (LPN) programs provide essential clinical skills and serve as a stepping stone to advanced nursing education.

Advancing further, many aspire to become Nurse Practitioners. There are multiple options for the easiest NP programs to get into, which can allow quicker entry while maintaining quality education.

For those focused on mental health, the top psychiatric mental health nurse practitioner programs online offer excellent clinical placement support, critical for hands-on experience in this specialized field.

Budget-conscious students should also consider the cheapest psychiatric nurse practitioner programs, which provide accessible pathways without compromising educational value.